Tandem Diabetes Care (TNDM) Other Non-Current Liabilities (2016 - 2026)
Tandem Diabetes Care filings provide 13 years of Other Non-Current Liabilities readings, the most recent being $49.7 million for Q4 2025.
- On a quarterly basis, Other Non-Current Liabilities rose 53.67% to $49.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $49.7 million, a 53.67% increase, with the full-year FY2025 number at $49.7 million, up 53.67% from a year prior.
- Other Non-Current Liabilities hit $49.7 million in Q4 2025 for Tandem Diabetes Care, down from $52.4 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $52.4 million in Q3 2025 to a low of $116000.0 in Q3 2021.
- Median Other Non-Current Liabilities over the past 5 years was $26.6 million (2021), compared with a mean of $27.8 million.
- Biggest five-year swings in Other Non-Current Liabilities: plummeted 99.33% in 2021 and later surged 19752.59% in 2022.
- Tandem Diabetes Care's Other Non-Current Liabilities stood at $17.8 million in 2021, then surged by 34.07% to $23.9 million in 2022, then soared by 33.08% to $31.8 million in 2023, then rose by 1.69% to $32.4 million in 2024, then surged by 53.67% to $49.7 million in 2025.
- The last three reported values for Other Non-Current Liabilities were $49.7 million (Q4 2025), $52.4 million (Q3 2025), and $52.1 million (Q2 2025) per Business Quant data.